Evaluation of the Combination of Docetaxel/Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Southwest Oncology Group Phase II Study

2007 ◽  
Vol 25 (3) ◽  
pp. 182-188 ◽  
Author(s):  
Wolfram E. Samlowski ◽  
James Moon ◽  
J. Philip Kuebler ◽  
Craig R. Nichols ◽  
David R. Gandara ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Oncology Group ◽  
Southwest Oncology Group ◽  
Recurrent Squamous Cell Carcinoma

A Phase II Study of Ifosfamide in Recurrent Squamous Cell Carcinoma of the Head and Neck

1996 ◽  
Vol 19 (4) ◽  
pp. 379-383 ◽  
Author(s):  
Martin H. Huber ◽  
Scott M. Lippman ◽  
Steven E. Benner ◽  
Mihran Shirinian ◽  
Isaiah W. Dimery ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Recurrent Squamous Cell Carcinoma

scholarly journals A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck

2014 ◽  
Vol 25 (9) ◽  
pp. 1813-1820 ◽  
Author(s):  
T.Y. Seiwert ◽  
J. Fayette ◽  
D. Cupissol ◽  
J.M. del Campo ◽  
P.M. Clement ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Study ◽  
Randomized Phase Ii ◽  
Recurrent Squamous Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document